|
| |
ImmunotherapyImmunotherapy, in medicine, refers to an array of treatment strategies based upon the concept of modulating the immune system to achieve a prophylactic and/or therapeutic goal. (From the Wikpedia article immunotherapy.) Download PDF containing detailed information.
Recent Publications on Immunotherapy: |  |
Abeta immunotherapy protects morphology and survival of adult-born neurons in doubly transgenic APP/PS1 mice.
The hippocampus is heavily affected by progressive neurodegeneration and... | 13th November, 2009
| Division of Psychiatry Research, University of Zurich, 8008 Zurich,
| J Neurosci. 2009 Nov 11;29(45):14108-19.
DOI Direct Link |
Redefining the role of interferon in the treatment of malignant diseases.
Interferon (IFN) is a cytokine with a long history of use as immunotherapy... | 13th November, 2009
| Department of Oncology and U.O.C. of Medical Oncology, Ospedale San
| Eur J Cancer. 2009 Nov 9.
DOI Direct Link |
Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
ABSTRACT: BACKGROUND: CD40 activation of antigen presenting cells (APC)... | 13th November, 2009
|
| J Transl Med. 2009 Nov 11;7(1):93.
DOI Direct Link |
Liposomes with high encapsulation capacity for paclitaxel: Preparation, characterisation and in vivo anticancer effect.
Paclitaxel (PTX) is approved for the treatment of ovarian and breast... | 12th November, 2009
| Department of Vaccinology and Immunotherapy, Veterinary Research
| J Pharm Sci. 2009 Nov 10.
DOI Direct Link |
Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy.
Our aim is to develop peptide vaccines that stimulate tumor... | 12th November, 2009
| Cancer Immunology and Immunotherapy Center, Saint Savas Cancer Hospital,
| Cancer Immunol Immunother. 2009 Nov 11.
DOI Direct Link |
→View more research publications. |
Press Releases About Immunotherapy:
|
 |
| Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies |
2nd November, 2009 |
Schering-Plough Corporation |
KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT
|
| Award-Winning Actor Danny Glover Featured on 'Sharing Miracles' |
23rd October, 2009 |
Pharmaceutical Research and Manufacturers of America |
WASHINGTON, Oct. 23 /PRNewswire-USNewswire/ -- A recent edition of Immunotherapy Weekly reported that the television program 'Sharing Miracles' featured award-winning actor Danny Glover
|
| Karmanos Cancer Institute Immunology Researcher Obtains Nearly $1 Million National Institutes of Health Grant |
20th October, 2009 |
Barbara Ann Karmanos Cancer Institute |
DETROIT, Oct. 20 /PRNewswire-USNewswire/ -- Venuprasad K. Poojary, Ph.D., assistant professor at the Barbara Ann Karmanos Cancer Institute and Wayne State University School of Medicine, has secured a
|
| Quest PharmaTech Acquires Late-Stage Immunotherapeutic Antibody Pipeline |
30th September, 2009 |
Quest PharmaTech Inc. |
TSX Venture: QPT
EDMONTON, Sept. 30 /PRNewswire-FirstCall/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing
|
| CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series |
10th July, 2009 |
CEL-SCI Corporation |
VIENNA, Va., July 10 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM), a late stage cancer immunotherapy company, announced today that Dr. Eyal Talor, CEL-SCI's Senior Vice
|
Companies working in the area of Immunotherapy from Bioportfolio's Biocorporate database : |  |
| Company Name | |
Allergy Immuno Technologies, Inc. (AIT) and its predecessors commenced development activities in allergy and immune disorder research diagnostic reagents and services in 1980. AIT currently operates a...
www.biomerica.com/html/allergyimmuno/ View full profile
| |
The Center of Molecular Immunology (CIM) is a Cuban Biotechnological Institution devoted to basic research, product development and production of mammalian cell culture products such as monoclonal...
www.cim.sld.cu/ View full profile
| |
AVAX Technologies is a development stage biopharmaceutical company which is acquiring and developing technologies and products for the treatment of cancer and other life-threatening diseases. The...
www.avax.com/ View full profile
| | →View more immunotherapy related companies. |
BioPortfolio Ltd. offers e-mail and postal lists for immunotherapy scientists - we have details of around 4209 individuals working on Immunotherapy . This page has been viewed 2937 times Recent Search Terms used to find this page: venuprasad poojary | how I treat cll upfront | Venuprasad poojary seminar microbiology immunology wayne state university | venture funding immunotherapy 2009 | Immunotherapy in Alzheimer s Disease Where Do We Stand Where Should We Go | case report cancer efficacy immunotherapy | is cuban medicine advanced in immunotherapy | cancer immunotherapy market report 2009 | immunotherapy and textbook | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for immunotherapy across BioPortfolio, or for immunotherapy Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|